Use of dipyridamole is associated with lower risk of lymphoid neoplasms: a propensity score-matched cohort study. Huang W, Sundquist K, Sundquist J, Ji J, et al. Br J Haematol 2022;196:690-699.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Huang W, Sundquist K, Sundquist J, Ji J, et al. Use of dipyridamole is associated with lower risk of lymphoid neoplasms: a propensity score-matched cohort study. Br J Haematol 2022;196:690-699.
PMID: 34553368